The abstract is read at the publisher; the summary is JClub's.
Neural repair therapies after stroke target surviving neural elements to promote post-acute plasticity, with FDA-approved vagus nerve stimulation and early candidates like cerebellar DBS showing promise.
- Why it matters: Acute treatments do not address recovery once injury has stabilized, leaving a need for evidence-based interventions that improve function during chronic poststroke stages.
- What they did: This review synthesizes advances across behavioral training (including constraint-induced movement therapy and telerehabilitation), drugs, biological agents (growth factors, monoclonal antibodies, stem cell approaches), and neural stimulation, emphasizing trial design lessons and clinical readiness.
- The result: Intensive behavioral interventions yield meaningful gains even in chronic stroke, while biological and pharmacological approaches show mixed or translational challenges; together, the evidence reshapes poststroke recovery and highlights opportunities for clinical translation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.